Home/Filings/4/0001222028-25-000008
4//SEC Filing

KAO JOHN E 4

Accession 0001222028-25-000008

CIK 0001832466other

Filed

Oct 13, 8:00 PM ET

Accepted

Oct 14, 4:39 PM ET

Size

6.2 KB

Accession

0001222028-25-000008

Insider Transaction Report

Form 4
Period: 2025-10-10
KAO JOHN E
DirectorChief Executive Officer
Transactions
  • Sale

    Common Stock

    2025-10-10$17.29/sh180,000$3,111,4802,706,726 total(indirect: See Footnote)
Holdings
  • Common Stock

    2,839,942
Footnotes (4)
  • [F1]Date of Rule 10b5-1 plan adoption: 03/12/2025
  • [F2]The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.97 to $17.60. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
  • [F3]Balances in column 5 reflect the transfer on 09/25/2025 of 1,693,626 shares held directly by Mr. Kao to the JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.
  • [F4]Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

Issuer

Alignment Healthcare, Inc.

CIK 0001832466

Entity typeother

Related Parties

1
  • filerCIK 0001222028

Filing Metadata

Form type
4
Filed
Oct 13, 8:00 PM ET
Accepted
Oct 14, 4:39 PM ET
Size
6.2 KB